Price & volume screen · refreshed after the Nov 11, 2026 close
Six-month momentum leaders: Healthcare
Large companies with the strongest six-month price performance. Ranks companies worth at least $1B by their six-month split-adjusted return.
| # | Company | Price | 1M | 6M | From high | Mkt cap |
|---|---|---|---|---|---|---|
| 51 | BIOBio-Rad LaboratoriesHealthcare | $387.97 | +6.7% | +59.3% | −0.6% | $10.43B |
| 52 | AGLagilon healthHealthcare | $114.67 | +33.5% | +59.2% | −42.9% | $1.93B |
| 53 | KYMRKymera TherapeuticsHealthcare | $135.76 | +27.3% | +58.6% | −2.2% | $11.59B |
| 54 | AAgilent TechnologiesHealthcare | $178.67 | +4.1% | +58.5% | −1.5% | $50.37B |
| 55 | PCRXPacira BioSciencesHealthcare | $36.48 | +0.5% | +58.3% | 0.0% | $1.46B |
| 56 | GHGuardant HealthHealthcare | $155.88 | −3.8% | +58.3% | −16.7% | $21.09B |
| 57 | CYRXCryoPortHealthcare | $20.92 | +23.4% | +57.9% | 0.0% | $1.06B |
| 58 | AMPHAmphastar PharmaceuticalsHealthcare | $28.91 | +11.0% | +57.8% | −1.7% | $1.23B |
| 59 | DFTXDefinium TherapeuticsHealthcare | $34.72 | +1.0% | +57.7% | −28.3% | $4.75B |
| 60 | CBLLCeriBellHealthcare | $27.78 | +6.3% | +55.1% | −1.8% | $1.08B |
| 61 | ADMAADMA BiologicsHealthcare | $13.09 | +26.9% | +53.9% | −35.8% | $2.90B |
| 62 | PGNYProgynyHealthcare | $36.09 | +31.7% | +53.5% | −0.9% | $2.66B |
| 63 | PRGOPERRIGOHealthcare | $16.70 | +8.6% | +53.0% | −1.5% | $2.32B |
| 64 | BAXBaxter InternationalHealthcare | $26.42 | +6.1% | +52.6% | −6.8% | $13.67B |
| 65 | MBXMBX BiosciencesHealthcare | $57.05 | +16.4% | +52.1% | −19.3% | $2.83B |
| 66 | TGTXTG TherapeuticsHealthcare | $64.75 | +19.2% | +51.8% | 0.0% | $9.79B |
| 67 | ILMNIlluminaHealthcare | $218.70 | −19.4% | +50.8% | −25.5% | $33.07B |
| 68 | RLAYRelay TherapeuticsHealthcare | $19.93 | +14.8% | +50.8% | −4.0% | $4.40B |
| 69 | RDNTRadNetHealthcare | $78.45 | +9.7% | +48.1% | −7.1% | $6.18B |
| 70 | BDXBecton, Dickinson andHealthcare | $212.47 | +13.4% | +47.4% | −1.3% | $57.87B |
| 71 | THCTenet Healthcare Corporation NewHealthcare | $288.34 | +8.0% | +47.2% | −1.3% | $22.95B |
| 72 | INSPInspire Medical SystemsHealthcare | $61.44 | −10.8% | +46.6% | −57.3% | $1.78B |
| 73 | ICUIICU MedicalHealthcare | $178.03 | +9.1% | +45.9% | −4.9% | $4.45B |
| 74 | HALOHalozyme TherapeuticsHealthcare | $102.10 | −6.9% | +45.8% | −22.2% | $11.64B |
| 75 | FTREFortrea HoldingsHealthcare | $21.08 | +0.8% | +45.7% | −18.5% | $2.03B |
| 76 | LHLabcorp HoldingsHealthcare | $370.38 | +18.1% | +45.6% | −0.4% | $30.07B |
| 77 | ZBIOZenas BioPharmaHealthcare | $28.81 | +14.5% | +44.6% | −33.3% | $1.95B |
| 78 | ROIVRoivant SciencesHealthcare | $42.22 | +26.6% | +44.5% | 0.0% | $30.59B |
| 79 | IMAXImaxHealthcare | $48.82 | −5.5% | +44.5% | −13.3% | $2.70B |
| 80 | SGPSpyGlass PharmaHealthcare | $34.42 | +43.9% | +44.5% | −10.3% | $1.15B |
| 81 | LGNDLigand PharmaceuticalsHealthcare | $317.91 | +4.7% | +43.7% | −1.5% | $6.36B |
| 82 | CNMDCONMEDHealthcare | $51.06 | +12.1% | +43.6% | −4.8% | $1.52B |
| 83 | UFPTUFP TechnologiesHealthcare | $314.60 | +6.9% | +43.5% | −6.0% | $2.44B |
| 84 | BRKRBrukerHealthcare | $62.76 | +11.7% | +43.1% | −5.7% | $9.58B |
| 85 | ACHCAcadia HealthcareHealthcare | $38.63 | +27.8% | +42.3% | 0.0% | $3.59B |
| 86 | TMDXTransMedics GroupHealthcare | $91.31 | +15.4% | +42.3% | −39.3% | $3.17B |
| 87 | WGSGeneDx HoldingsHealthcare | $55.36 | −14.8% | +42.2% | −67.0% | $1.66B |
| 88 | MANEVeradermics, IncorporatedHealthcare | $152.28 | +31.0% | +42.1% | 0.0% | $6.36B |
| 89 | ITGRInteger HoldingsHealthcare | $126.67 | +0.1% | +41.7% | −0.1% | $4.31B |
| 90 | WATWatersHealthcare | $474.13 | +10.5% | +41.6% | −1.2% | $46.58B |
| 91 | KMTSKestra Medical TechnologiesHealthcare | $30.33 | +12.4% | +41.4% | −0.9% | $1.81B |
| 92 | VIRVir BiotechnologyHealthcare | $13.17 | +24.1% | +41.1% | −3.5% | $2.25B |
| 93 | EWTXEdgewise TherapeuticsHealthcare | $47.53 | +31.0% | +40.8% | −2.5% | $5.20B |
| 94 | LLYEli Lilly &Healthcare | $1,429.05 | +22.5% | +40.7% | −0.2% | $1.27T |
| 95 | ABBVABBVIEHealthcare | $292.87 | +6.7% | +40.5% | −0.7% | $517.68B |
| 96 | MMSIMerit Medical SystemsHealthcare | $87.79 | −0.4% | +40.2% | −6.8% | $5.26B |
| 97 | SYRESpyre TherapeuticsHealthcare | $105.98 | +31.7% | +38.9% | −2.8% | $10.06B |
| 98 | LBRXLB PharmaceuticalsHealthcare | $44.67 | +28.4% | +38.2% | −9.7% | $1.45B |
| 99 | AMGNAmgenHealthcare | $464.25 | +12.5% | +38.0% | −3.0% | $251.12B |
| 100 | MAZEMaze TherapeuticsHealthcare | $37.17 | +39.4% | +37.9% | −28.3% | $2.03B |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.